FDA Inspection 1078694 — LNK International, Inc.

LNK International, Inc. — FEI 2432212

The FDA completed an inspection of LNK International, Inc. on Feb 8, 2019 in Hauppauge, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 8, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hauppauge, NY (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
360321 CFR 211.160(b)Scientifically sound laboratory controls
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.